New Zealand markets closed

MedinCell S.A. (MEDCL.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
13.26-0.14 (-1.04%)
At close: 05:35PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Total revenue
10,902
9,944
4,090
8,186
2,852
Cost of revenue
-
-
0
0
969
Gross profit
-
-
4,090
8,186
1,883
Operating expenses
Research development
24,337
27,925
23,607
19,546
17,214
Total operating expenses
32,271
33,989
27,906
23,762
21,208
Operating income or loss
-21,369
-24,045
-23,816
-15,576
-19,325
Interest expense
4,502
3,932
1,844
2,267
2,113
Income before tax
-26,421
-32,010
-24,806
-18,986
-21,442
Income tax expense
-
-
0
0
2,473
Income from continuing operations
-26,421
-32,010
-24,806
-18,986
-23,915
Net income
-26,421
-32,010
-24,806
-18,986
-23,915
Net income available to common shareholders
-26,421
-32,010
-24,806
-18,986
-23,915
Basic EPS
-1.01
-1.27
-1.00
-0.86
-1.19
Diluted EPS
-1.01
-1.27
-1.00
-0.86
-1.19
Basic average shares
26,546
25,188
24,865
22,044
20,110
Diluted average shares
26,546
25,188
24,865
22,044
20,110